Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Epizyme Inc (NQ: EPZM )

8.095 USD -0.135 (-1.64%)
Official Closing Price Updated: 6:18 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Epizyme Inc

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Interesting EPZM Put And Call Options For June 18th
Investors in Epizyme Inc. (EPZM) saw new options become available today, for the June 18th expiration.. 
Tags Stocks
From Market News Video
Analysts See 12% Upside For The Holdings of JKK
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cara Therapeutics (NASDAQ:CARA) shares rose 11.88% to $26.65 during Tuesday's pre-market session. The ... 
Tags MTP Top Gainers APTX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021
Upgrades Barclays upgraded the previous rating for Textron Inc (NYSE:TXT) from Equal-Weight to Overweight. In the fourth ... 
Tags XYL BHP KMX
From Benzinga
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ORPH RHHBY Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks GNMK RXDX
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NLTX UPC DBTX
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 26 companies set new 52-week lows. Intriguing Points: The company with the ... 
Tags CNCE Benzinga AFIB
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning saw 16 companies set new 52-week lows. Things to Consider: The largest company by market ... 
Tags EPZM Market News 52 Week Lows
From Benzinga
First Week of EPZM November 19th Options Trading
Investors in Epizyme Inc. (EPZM) saw new options become available this week, for the November 19th expiration.. 
Tags Stocks
From Market News Video
28 Stocks Moving in Tuesday's Pre-Market Session
Gainers SunLink Health Systems, Inc. (NYSE: SSY) shares rose 82.4% to $3.52 in pre-market trading as the company reported $2 ... 
Tags YTRA News CHNR
From Benzinga
Analysts Anticipate XBI Will Reach $220
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks That Hit 52-Week Lows On Friday
During Friday's morning trading, 2 companies set new 52-week lows. Things to Consider: New Oriental Education ... 
Tags Movers Benzinga EDU
From Benzinga
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CEMI BTAI SVRA
From Benzinga
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News OLMA IMRA
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 61 companies reached new 52-week lows. Areas of Significance: The largest company in ... 
Tags XPOA HKIB EPZM
From Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FRLN INMB TARA
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 8 companies made new 52-week lows. Things to Consider: Viatris ... 
Tags 52/Week Lows Market News EPZM
From Benzinga
Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic... 
From Business Wire News Releases
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 24 stocks hit new 52-week lows. Noteworthy Points: Viatris ... 
Tags DNB BZI/52Weeks OPT
From Benzinga
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MRK DRNA ORGO
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2021
Upgrades For Lowe's Companies Inc (NYSE:LOW), Gordon Haskett upgraded the previous rating of Accumulate to Buy. ... 
Tags Intraday Update PNW TJX
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 1 companyreached new 52-week lows. Epizyme (NASDAQ:EPZM) shares were down 1.86% for ... 
Tags Market News Movers 52/Week Lows
From Benzinga
Epizyme to Host Strategic Vision Call on March 2, 2021
Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that it will host a call to discuss the... 
From Business Wire News Releases
Epizyme Inc (EPZM) Q4 2020 Earnings Call Transcript
EPZM earnings call for the period ending December 31, 2020. 
Tags Market News EPZM
From Motley Fool
CORRECTING and REPLACING Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Third subhead of release should read: Safety Run-In Portion of Confirmatory Trials of TAZVERIK® in ES and FL and Phase 1b Portion of Phase 1b/2 Castration-Resistant Prostate Cancer Fully Enrolled;... 
From Business Wire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MASI RDHL CTXR
From Benzinga
Epizyme: Q4 Earnings Insights
Shares of Epizyme (NASDAQ:EPZM) rose 3.4% in pre-market trading after the company reported Q4 results. Quarterly ... 
Tags News Market News EPZM
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags HD EPRT CLVS
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags ALIM ICPT EDIT
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.